Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Charlton

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1997
Liver transplantation for cryptogenic cirrhosisM R Charlton, M Kondo, S K Roberts, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 8, 2014
Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor sizeD J Kim, P J Clark, J Heimbach, et al.
Transplantation|August 10, 2000
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseasesY Maor-Kendler, K P Batts, L J Burgart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 18, 2013
Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of diseaseK D Watt, R Dierkhising, C Fan, et al.
The American Journal of Gastroenterology|March 10, 2000
Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markersP J Cleavinger, D H Persing, H Li, et al.
Transplantation|February 3, 1998
Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring?M R Charlton, D Brandhagen, R H Wiesner, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2010
Daclizumab induction therapy in liver transplant recipients with renal insufficiencyS K Asrani, W R Kim, R A Pedersen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 17, 2001
Recurrent autoimmune hepatitis after orthotopic liver transplantationA González-Koch, A J Czaja, H A Carpenter, et al.
The American Journal of Gastroenterology|October 16, 1999
Clinical significance of TT virus infection in patients with chronic hepatitis CN N Zein, M Arslan, H Li, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantationR Sreekumar, A Gonzalez-Koch, Y Maor-Kendler, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1997
Liver transplantation for cryptogenic cirrhosisM R Charlton, M Kondo, S K Roberts, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 8, 2014
Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor sizeD J Kim, P J Clark, J Heimbach, et al.
Transplantation|August 10, 2000
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseasesY Maor-Kendler, K P Batts, L J Burgart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 18, 2013
Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of diseaseK D Watt, R Dierkhising, C Fan, et al.
The American Journal of Gastroenterology|March 10, 2000
Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markersP J Cleavinger, D H Persing, H Li, et al.
Transplantation|February 3, 1998
Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring?M R Charlton, D Brandhagen, R H Wiesner, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2010
Daclizumab induction therapy in liver transplant recipients with renal insufficiencyS K Asrani, W R Kim, R A Pedersen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 17, 2001
Recurrent autoimmune hepatitis after orthotopic liver transplantationA González-Koch, A J Czaja, H A Carpenter, et al.
The American Journal of Gastroenterology|October 16, 1999
Clinical significance of TT virus infection in patients with chronic hepatitis CN N Zein, M Arslan, H Li, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantationR Sreekumar, A Gonzalez-Koch, Y Maor-Kendler, et al.
Pageof 4